These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 9797004)
1. Immunohistochemical demonstration of tissue transglutaminase in amyloid plaques. Zhang W; Johnson BR; Suri DE; Martinez J; Bjornsson TD Acta Neuropathol; 1998 Oct; 96(4):395-400. PubMed ID: 9797004 [TBL] [Abstract][Full Text] [Related]
2. Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide. Dudek SM; Johnson GV Brain Res; 1994 Jul; 651(1-2):129-33. PubMed ID: 7922559 [TBL] [Abstract][Full Text] [Related]
3. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease. Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982 [TBL] [Abstract][Full Text] [Related]
4. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity. de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696 [TBL] [Abstract][Full Text] [Related]
5. Tissue transglutaminase in Alzheimer's disease: involvement in pathogenesis and its potential as a therapeutic target. Wilhelmus MM; de Jager M; Bakker EN; Drukarch B J Alzheimers Dis; 2014; 42 Suppl 3():S289-303. PubMed ID: 24685636 [TBL] [Abstract][Full Text] [Related]
6. Identification of glutamine and lysine residues in Alzheimer amyloid beta A4 peptide responsible for transglutaminase-catalysed homopolymerization and cross-linking to alpha 2M receptor. Rasmussen LK; Sørensen ES; Petersen TE; Gliemann J; Jensen PH FEBS Lett; 1994 Jan; 338(2):161-6. PubMed ID: 7905838 [TBL] [Abstract][Full Text] [Related]
7. Pharmacologic inhibition of transglutaminase-induced cross-linking of Alzheimer's amyloid beta-peptide. Zhang W; Johnson BR; Bjornsson TD Life Sci; 1997; 60(25):2323-32. PubMed ID: 9194688 [TBL] [Abstract][Full Text] [Related]
8. Interaction between tissue transglutaminase and amyloid-beta: Protein-protein binding versus enzymatic crosslinking. Wilhelmus MMM; Jongenelen CA; Bol JGJM; Drukarch B Anal Biochem; 2020 Mar; 592():113578. PubMed ID: 31923381 [TBL] [Abstract][Full Text] [Related]
9. N-truncated Aβ Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359 [TBL] [Abstract][Full Text] [Related]
10. Residues in the synuclein consensus motif of the alpha-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid beta A4 peptide. Jensen PH; Sørensen ES; Petersen TE; Gliemann J; Rasmussen LK Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):91-4. PubMed ID: 7646476 [TBL] [Abstract][Full Text] [Related]
11. Transglutaminase induces protofibril-like amyloid beta-protein assemblies that are protease-resistant and inhibit long-term potentiation. Hartley DM; Zhao C; Speier AC; Woodard GA; Li S; Li Z; Walz T J Biol Chem; 2008 Jun; 283(24):16790-800. PubMed ID: 18397883 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease. Kim SY; Grant P; Lee JH; Pant HC; Steinert PM J Biol Chem; 1999 Oct; 274(43):30715-21. PubMed ID: 10521460 [TBL] [Abstract][Full Text] [Related]
13. Cross-linking of a synthetic partial-length (1-28) peptide of the Alzheimer beta/A4 amyloid protein by transglutaminase. Ikura K; Takahata K; Sasaki R FEBS Lett; 1993 Jul; 326(1-3):109-11. PubMed ID: 8100780 [TBL] [Abstract][Full Text] [Related]
14. Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer's disease mouse models. Wilhelmus MM; de Jager M; Smit AB; van der Loo RJ; Drukarch B Sci Rep; 2016 Feb; 6():20569. PubMed ID: 26837469 [TBL] [Abstract][Full Text] [Related]
15. Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer's disease. Kumar-Singh S; De Jonghe C; Cruts M; Kleinert R; Wang R; Mercken M; De Strooper B; Vanderstichele H; Löfgren A; Vanderhoeven I; Backhovens H; Vanmechelen E; Kroisel PM; Van Broeckhoven C Hum Mol Genet; 2000 Nov; 9(18):2589-98. PubMed ID: 11063718 [TBL] [Abstract][Full Text] [Related]
16. Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease. Rozemuller AJ; Roos RA; Bots GT; Kamphorst W; Eikelenboom P; Van Nostrand WE Am J Pathol; 1993 May; 142(5):1449-57. PubMed ID: 7684195 [TBL] [Abstract][Full Text] [Related]
17. Presence of hydroxysteroid dehydrogenase type 10 in amyloid plaques (APs) of Hsiao's APP-Sw transgenic mouse brains, but absence in APs of Alzheimer's disease brains. Wen GY; Yang SY; Kaczmarski W; He XY; Pappas KS Brain Res; 2002 Nov; 954(1):115-22. PubMed ID: 12393239 [TBL] [Abstract][Full Text] [Related]
18. The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP. Iismaa SE; Chung L; Wu MJ; Teller DC; Yee VC; Graham RM Biochemistry; 1997 Sep; 36(39):11655-64. PubMed ID: 9305955 [TBL] [Abstract][Full Text] [Related]